Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Large scale production of BRICHOS

Reference number
Coordinator Briccos AB
Funding from Vinnova SEK 960 000
Project duration November 2026 - April 2028
Status Ongoing
Venture Research infrastructure - utilisation and collaboration
Call Support to small and medium-sized companies for the use of life science infrastructure

Purpose and goal

We have found that the protein BRICHOS is a very promisin candidate for developing a new drug against Alzheimer´s disease. We lack resources within Briccos AB for large-scale handling of bacterial cultures for optimization of downstream processing. In this project we plan to develop large-scale methods for release, extraction and clarification of recombinant BRICHOS with the help of NorthX AB.

Expected effects and result

We expect that the project will lead to the establishment of methods and protocols to optimize the release and extraction, clearance, concentration and buffer exchange of BRICHOS produced in large-scale E. coli. These methods and protocols will lay the ground for setting up a GLP process for the manufacture of BRICHOS protein for preclinical toxicology studies.

Planned approach and implementation

The project requires access to specialized infrastructure for downstream process development, tangential flow filtration (TFF) systems and process development expertise – resources that are not available within Briccos AB. Genom NorthX Biologics Innovation Hub provides Bricco with access to industrially relevant development equipment, process development know-how and scale-up expertise, which is necessary to establish a future manufacturing process for BRICHOS.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 4 November 2026

Reference number 2026-02998